First Light Fusion is pioneering a novel target-based approach to accelerate the delivery of practical, commercially viable fusion energy.
Molecular landscape and therapeutic vulnerability of RRAS- and RRAS2-mutant solid tumors. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results